CIK: 0002013341
Total reported value
$460.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CGON | Cg Oncology INC | Stock-Other | 29.80% | +4.79% | — | |
| 2 | ALMS | Alumis INC | Stock-Other | 14.14% | +7.80% | — | |
| 3 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 9.87% | +1.46% | — | |
| 4 | ✓ | Rapt Therapeutics INC | Stock-Other | 8.35% | — | — | |
| 5 | AKRO | Akero Therapeutics INC | Stock-Other | 8.09% | — | — | |
| 6 | EWTX | Edgewise Therapeutics INC | Stock-Other | 7.05% | — | — | |
| 7 | BCAX | Bicara Therapeutics INC | Stock-Other | 6.78% | — | — | |
| 8 | GPCR | Structure Therapeutics INC | Stock-Other | 3.98% | — | — | |
| 9 | ALLO | Allogene Therapeutics INC | Stock-Other | 2.76% | — | — | |
| 10 | CRVS | Corvus Pharmaceuticals INC | Stock-Other | 2.75% | +2.61% | — | |
| 11 | CGEM | Cullinan Therapeutics INC | Stock-Other | 2.63% | — | — | |
| 12 | KYMR | Kymera Therapeutics INC | Stock-Other | 2.19% | -0.79% | — | |
| 13 | ✓ | Casi Pharmaceuticals INC | Stock-Other | 1.57% | — | — | |
| 14 | VRDN | Viridian Therapeutics INC | Stock-Other | 0.01% | — | — |